ABBOTT LABORATORIES — Proxy Solicitation & Information Statement 2023

Mar 17, 2023

DEFA14A 1 abt4116441_defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

☑ Filed by the Registrant ☐ Filed by a party other than the Registrant

CHECK THE APPROPRIATE BOX:
☐	Preliminary Proxy Statement
☐	Confidential, for Use of the Commission Only
(as permitted by Rule 14a-6(e)(2))
☐	Definitive Proxy Statement
☑	Definitive Additional Materials
☐	Soliciting Material under §240.14a-12

Abbott Laboratories

(Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

PAYMENT OF FILING FEE (CHECK ALL BOXES THAT APPLY):
☑	No fee required
☐	Fee paid previously with preliminary materials
☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

●
C 1234567890
●	Online Go to www.investorvote.com/abt. or scan the QR code — login
details are located in the shaded bar below.

Annual Meeting Notice

Important Notice Regarding the Availability of Proxy Materials for the Abbott Laboratories Annual Meeting of Shareholders to be held on April 28, 2023

Under Securities and Exchange Commission rules, you are receiving this notice that the proxy materials for the Annual Meeting of Shareholders are available on the Internet. Follow the instructions below to view the materials and vote online or request a paper copy. The items to be voted on and location of the annual meeting are on the reverse side. Your vote is important!

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The 2023 proxy statement and 2022 annual report to shareholders are available at:

www.investorvote.com/abt

●
Step 1:	Go
to www.investorvote.com/abt.
Step
2:	Click on the icon
on the right to view meeting materials.
Step
3:	Return to the investorvote.com
window and follow the instructions on the screen to log in.
Step
4:	Make your selections
as instructed on each screen for your delivery preferences.
Step
5:	Vote your shares.

When you go online, you can also help the environment by consenting to receive electronic delivery of future materials.

Obtaining a Copy of the Proxy Materials – If you want to receive a paper copy of the proxy materials, you must request one. There is no charge to you for this request. Please make your request as instructed on the reverse side of this Notice on or before April 14, 2023 to facilitate timely delivery.

2 N O T C O Y

03R6DC

Annual Meeting Notice

The 2023 Annual Meeting of Shareholders will be held at 9:00 a.m. Central Time on Friday, April 28, 2023, at meetnow.global/ABT2023. There will not be a physical location for the Annual Meeting, and shareholders will not be able to attend the Annual Meeting in person.

How to Attend the Meeting on the Virtual Meeting Platform. Shareholders will be able to attend, vote their shares, and submit questions during the Annual Meeting at meetnow.global/ABT2023. To be admitted to the meeting, you must have the 15-digit control number printed on the reverse side of this form.

How to Attend the Meeting by Phone. Shareholders who wish to attend the meeting by phone should contact Abbott representatives at 224-668-7238 or abbottshareholders@abbott.com to obtain the meeting telephone number in advance of the meeting. Shareholders participating by phone will be able to listen to the meeting but will not have the ability to vote or submit questions during the meeting.

Items to be voted on at the meeting are listed below along with the Board of Directors’ recommendations.

The Board of Directors recommends a vote FOR all the nominees listed in Item 1, FOR Items 2 and 3, and 1 YEAR on Item 4:

1. — 01 – R. J. Alpern	02 – C. Babineaux-Fontenot	03 – S. E. Blount	04 – R. B. Ford
05 – P. Gonzalez	06 – M. A. Kumbier	07 – D. W. McDew	08 – N. McKinstry
09 – M. G. O’Grady	10 – M. F. Roman	11 – D. J. Starks	12 – J. G. Stratton

| | Ratification
of Ernst & Young LLP As Auditors |
| --- | --- |
| 3. | Say on Pay - An Advisory
Vote on the Approval of Executive Compensation |
| 4. | Say When on Pay - An
Advisory Vote on the Approval of the Frequency of Shareholder Votes on Executive Compensation |
| The Board of Directors recommends a vote AGAINST Items 5, 6, 7, and 8. | |
| 5. | Shareholder Proposal
– Special Shareholder Meeting Threshold |
| 6. | Shareholder Proposal
– Independent Board Chairman |
| 7. | Shareholder Proposal
– Lobbying Disclosure |
| 8. | Shareholder Proposal
– Incentive Compensation |

PLEASE NOTE – YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must vote online or request a paper copy of the proxy materials to receive a proxy card. If you wish to attend and vote at the meeting, please follow the instructions provided above.

Instructions for virtually attending the Abbott Laboratories 2023 Annual Meeting of Shareholders are also available in the proxy statement, which can be viewed at www.investorvote.com/abt .

●
Current and future delivery requests can be submitted using the options below.
If you request an email copy, you will receive an email with a link to the current meeting materials.
PLEASE
NOTE: You must use the number in the shaded bar on the reverse side of this Notice when requesting a copy of the proxy
materials.
—	Internet – Go to www.investorvote.com/abt.
—	Phone –
Call us free of charge at 1-866-641-4276.
—	Email –
Send an email to investorvote@computershare.com
with “Proxy Materials Abbott Laboratories”
in the subject line. Include your full name and address, plus the number located in the shaded bar on the reverse side of
this Notice, and state that you want a paper copy of the proxy materials.
	To facilitate timely delivery, requests for a paper
copy of proxy materials must be received by April 14, 2023.